MicroPort CardioFlow Medtech
Shanghai MicroPort CardioFlow Medtech provides advanced minimally invasive therapies for structural heart diseases.
Business Model: Consulting
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed MicroPort CardioFlow Medtech Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$130M
Raised Total:$130M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&a;D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.
Contact Phone:
Contact Email:
MicroPort CardioFlow Medtech went public on the Hong Kong Stock Exchange
Listed Exchange:
Hong Kong Stock Exchange
Ticker Symbol:
02160
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2022 | 4C Medical Technologies | Series C | 0 |
| 3/2022 | 4C Medical Technologies | Series C | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
